...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Inhibitory effects of tamoxifen and tanshinone, alone or in combination, on the proliferation of breast cancer cells via activation of p38 MAPK signalling pathway
【24h】

Inhibitory effects of tamoxifen and tanshinone, alone or in combination, on the proliferation of breast cancer cells via activation of p38 MAPK signalling pathway

机译:他莫昔芬和丹参酮单独或组合通过激活p38 MAPK信号通路对乳腺癌细胞的增殖抑制作用

获取原文
           

摘要

Purpose: To investigate the effects of tamoxifen and tanshinone administered individually or in combination, on the proliferation of breast cancer (BC) cells, and the underlying mechanism(s) of action. Methods: Human breast cancer cell lines (SNU-306, SNU-334 and SNU-1528), and normal primary mammary epithelial cell line (HMEC) were cultured at 37 °C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 % fetal bovine serum (FBS), l glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 μg/ml) in a humidified incubator containing 5 % CO 2 . Cell proliferation was determined using MTT assay, while real-time quantitative polymerase chain reaction (qRT-PCR) was used to determine the ex pressions of apoptosis-related genes. The ex pressions of p38 mitogen-activated protein kinases (p38 MAPK) were determined by Western blotting. Results: There were only few viable cells in tamoxifen- and tanshinone-treated wells, and cell viability was concentration-dependently reduced. Treatment of SNU-306 cells with tamoxifen (30 μM) or tanshinone (20 μM) alone significantly reduced the ex pression of Wip1 after 72 h of incubation, and the level of ex pression was significantly reduced in SNU-306 cells treated with combination of tamoxifen and tanshinones, relative to those treated with tamoxifen or tanshinone alone (p 0.05). The extent of apoptosis was significantly higher in SNU-306 cells treated with tamoxifen or tanshinone alone or in combination than in control cells (p 0.05). ex pressions of Bax, caspase 3 and p53 were significantly higher in SNU-306 cells than in control cells, and were significantly higher in SNU-306 cells treated with combination of tamoxifen and tanshinone than in those treated with tamoxifen or tanshinone alone (p 0.05). The level of ex pression of MAPK was significantly higher in SNU-306 cells treated with tamoxifen or tanshinone alone, and in combination treatment, than in control cells (p 0.05). Conclusion: Tamoxifen and tanshinone administered alone or in combination promote apoptosis in BC cells via mechanisms involving the up-regulation and phosphorylation of MAPK.
机译:目的:研究他莫昔芬和丹参酮单独或组合给药对乳腺癌(BC)细胞增殖及其作用机制的影响。方法:将人类乳腺癌细胞系(SNU-306,SNU-334和SNU-1528)以及正常的原代乳腺上皮细胞系(HMEC)在37°C的Dulbecco改良的Eagle's培养基(DMEM)中添加5%的胎儿,牛血清(FBS),l谷氨酰胺(2 mM),青霉素(100 U / ml)和链霉素(100μg/ ml)在含有5%CO 2的加湿培养箱中。使用MTT分析确定细胞增殖,同时使用实时定量聚合酶链反应(qRT-PCR)确定凋亡相关基因的表达。通过蛋白质印迹确定p38丝裂原活化蛋白激酶(p38 MAPK)的表达。结果:在他莫昔芬和丹参酮处理的孔中,存活细胞很少,并且细胞存活率浓度依赖性降低。单独使用他莫昔芬(30μM)或丹参酮(20μM)处理SNU-306细胞后,孵育72小时后,Wip1的表达显着降低,并且在联合使用SNU-306的SNU-306细胞中,表达水平明显降低他莫昔芬和丹参酮,相对于单独使用他莫昔芬或丹参酮治疗的患者(p <0.05)。单独或联合使用他莫昔芬或丹参酮处理的SNU-306细胞的凋亡程度明显高于对照细胞(p <0.05)。 Bax,caspase 3和p53的表达在SNU-306细胞中显着高于对照细胞,在用他莫昔芬和丹参酮联合处理的SNU-306细胞中显着高于单独用他莫昔芬或丹参酮处理的细胞(p < 0.05)。在单独使用他莫昔芬或丹参酮以及联合治疗的SNU-306细胞中,MAPK的表达水平明显高于对照细胞(p <0.05)。结论:单独或联合使用他莫昔芬和丹参酮可通过涉及MAPK上调和磷酸化的机制促进BC细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号